About Pentavere Research Group
Pentavere is an early-stage digital health company working with 6 of the top-10 largest pharmaceutical in the world. The company is the developer of a proprietary artificial intelligence (AI) engine that is proven and validated to transform complex clinical documentation into usable real-world evidence and lifesaving insights. Pentavere’s big pharma customers have deployed its AI technology across their entire value chains to inform strategic decisions and enhance clinical workflows, improving operational efficiencies and saving significant costs. The company was founded in 2016 and is based in Toronto, Ontario.
Pentavere Research Group's Product Videos
Pentavere Research Group's Products & Differentiators
Pentavere's proven and in production AI identifies patients who are: 1) eligible for, but not yet on approved medications 2) eligible for, medical interventions and procedures.
Expert Collections containing Pentavere Research Group
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Pentavere Research Group is included in 2 Expert Collections, including Value-Based Care & Population Health.
Value-Based Care & Population Health
The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Latest Pentavere Research Group News
Jan 18, 2023
January 18, 2023 TORONTO – Filomena Tassi (pictured), Minister responsible for the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), announced over $14 million towards the scale-up and growth of eight GTA-based companies: Able Innovations Inc., BeWhere Inc., BlueDot Inc., Cognota Inc., Earth Boring Co., Mero Technologies Inc., Pentavere Research Group Inc. and Schlesinger Group Ltd. As a result of this investment, these companies will be able to grow digital and manufacturing solutions, move towards green operations, enhance data in healthcare settings and improve monitoring and tracking software, while also creating over 230 jobs across the GTA. “Supporting Canadian innovators as they modernize and develop new processes, technologies and products to improve the way Canadians live and do business is critical. Today’s $14-million investment from the Government of Canada for eight GTA businesses highlights our commitment to creating jobs, investing in clean technologies and growing the economy,” said Minister Tassi. The Toronto region is Canada’s largest financial contributor, accounting for 20 percent of the gross domestic product, and is home to more than 40 percent of the country’s business headquarters. The company’s receiving funding include three healthcare technology organizations: Able Innovations Inc. Established in 2018, Toronto-based Able Innovations Inc. has developed innovative robotic technology that enables front-line healthcare staff to conduct safe and easy patient transfer solutions. This repayable investment will enable the healthcare tech company to acquire advanced manufacturing equipment to bring its patient transfer platform to market, obtain regulatory approvals and enhance add-on features. As a result, the company will bring a new, much-needed medical device into clinics and hospitals and will create 24 skilled jobs. ($797,031) Pentavere Research Group Inc. Established in 2016, Toronto-based Pentavere Research Group Inc. is an award-winning developer of the breakthrough DARWEN AI engine which empowers clinicians and pharmaceutical partners to access critical, lifesaving information that is buried within large amounts of complex, clinical text data. This repayable investment will allow the healthcare tech company to scale the development and commercialization of its data management processing software, DARWEN Clinical Trial and DARWEN Customer Voice AI, which rapidly extracts, structures, and analyses complex clinical data for healthcare providers and technology partners. As a result, the company will increase revenues and create 10 skilled jobs. ($1,060,000) BlueDot Inc. Founded in 2013, Toronto-based BlueDot Inc. has built and commercialized an advanced, real-time, early-warning service that combines artificial and human intelligence to anticipate and manage disruption from the growing number of infectious disease threats appearing around the world. The company gained international recognition after detecting and warning its public and private sector clients of COVID-19, nearly a week before the World Health Organization, and for using its predictive modelling technology to accurately forecast its spread and impacts globally. This repayable investment will support the software company to accelerate adoption and strengthen its global epidemic intelligence and threat monitoring platform. As a result, the company will expand its client base, help detect future outbreaks and meet the increased demand for its tech, while also creating 40 skilled jobs. ($3,000,000) Since 2015, the Government of Canada, through FedDev Ontario, has invested over $900 million in more than 1,280 projects in the Greater Toronto Area creating over 30,000 jobs and maintaining over 45,000 jobs.
Pentavere Research Group Frequently Asked Questions (FAQ)
When was Pentavere Research Group founded?
Pentavere Research Group was founded in 2016.
Where is Pentavere Research Group's headquarters?
Pentavere Research Group's headquarters is located at 661 University Avenue, Toronto.
What is Pentavere Research Group's latest funding round?
Pentavere Research Group's latest funding round is Incubator/Accelerator.
Who are the investors of Pentavere Research Group?
Investors of Pentavere Research Group include JLabs.
Who are Pentavere Research Group's competitors?
Competitors of Pentavere Research Group include nference and 6 more.
What products does Pentavere Research Group offer?
Pentavere Research Group's products include Patient Identification.
Compare Pentavere Research Group to Competitors
Evidation operates as a multichannel health tracking platform. It enables users to connect with multiple appications to track everyday activity and earn rewards for steps, sleep, surveys, and more. The company was founded in 2012 and is based in San Mateo, California.
Owkin specializes in developing artificial intelligence (AI) technologies for clinical research and developing drugs and treatments for patients. It empowers researchers in hospitals, universities, and the biopharmaceutical industry to understand drug efficacy varies, improves the drug development process, and help identify key drugs and treatments for individual patients to improve patient outcomes. The company was founded in 2016 and is based in New York, New York.
ConcertAI is a healthcare technology company. It uses artificial intelligence (AI) to help oncologists make more informed treatment decisions for their patients. The platform analyzes large datasets of clinical and genomic data to identify patterns and insights which is used for personalized cancer treatment. It was formerly known as Precision HealthAI. It was founded in 2017 and is based in Cambridge, Massachusetts.
Autonomize automates insights from multi-structured clinical and biomedical data, to help healthcare organizations make critical decisions. It specializes in machine learning, deep learning, health tech, and artificial intelligence. The company's products include Autonomize Pixel helps accelerates clinical trials through workflows and optimal protocol design, feasibility studies, and patient matching; Autonomize Wizard augments clinical decisions by providing multi-modal chart insights for research, payer administration, registries, and decision-making; and Generative AI offers conversational, search and summarization capabilities for secure internal data sources, contextualized for different user types. Autonomize was founded in 2021 and is based in Austin, Texas.
Holmusk builds an evidence platform with behavioral health combining behavioral health databases with artificial intelligence (AI) powered analytics and digital solutions. Its technology powers data-driven medicine that uses analytic and digital tools to address the need in healthcare and pharma-life science. The company was founded in 2015 and is based in Singapore, Singapore.
Syapse develops software for aggregating and structuring biomedical data. It combines data intelligence, insight analytics and applied experience through healthcare organizations looking to transform patients’ lives using real-world evidence. The company was founded in 2008 and is based in San Francisco, California.